Canada Life’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.7M Buy
287,149
+7,015
+3% +$1.34M 0.09% 206
2025
Q4
$52.7M Sell
280,134
-217,473
-44% -$41M 0.09% 182
2025
Q3
$101M Buy
497,607
+13,324
+3% +$2.85M 0.15% 125
2025
Q2
$108M Sell
484,283
-20,172
-4% -$4.34M 0.17% 117
2025
Q1
$104M Sell
504,455
-8,701
-2% -$1.73M 0.18% 107
2024
Q4
$93.6M Sell
513,156
-29,154
-5% -$6.13M 0.16% 110
2024
Q3
$112M Sell
542,310
-13,170
-2% -$2.54M 0.19% 100
2024
Q2
$97M Buy
555,480
+120,008
+28% +$20.5M 0.18% 106
2024
Q1
$74.8M Sell
435,472
-19,276
-4% -$2.97M 0.15% 130
2023
Q4
$68.2M Buy
454,748
+15,708
+4% +$2.1M 0.15% 133
2023
Q3
$52.8M Buy
439,040
+25,672
+6% +$3.2M 0.13% 153
2023
Q2
$51.6M Buy
413,368
+51,924
+14% +$6.09M 0.12% 165
2023
Q1
$41.8M Buy
361,444
+7,120
+2% +$785K 0.1% 199
2022
Q4
$40.2M Buy
354,324
+58,420
+20% +$6.32M 0.11% 208
2022
Q3
$28.7M Buy
295,904
+6,712
+2% +$685K 0.08% 242
2022
Q2
$27M Sell
289,192
-14,500
-5% -$1.41M 0.07% 274
2022
Q1
$34.1M Sell
303,692
-4,820
-2% -$469K 0.07% 278
2021
Q4
$34.1M Buy
308,512
+15,624
+5% +$1.68M 0.07% 284
2021
Q3
$28M Sell
292,888
-16,164
-5% -$1.58M 0.07% 308
2021
Q2
$29.5M Sell
309,052
-10,388
-3% -$921K 0.07% 310
2021
Q1
$27.1M Buy
319,440
+16,196
+5% +$1.37M 0.07% 315
2020
Q4
$26.7M Buy
303,244
+16,736
+6% +$1.45M 0.05% 358
2020
Q3
$23.8M Sell
286,508
-10,092
-3% -$778K 0.05% 339
2020
Q2
$19.7M Sell
296,600
-13,140
-4% -$760K 0.05% 369
2020
Q1
$13.5M Sell
309,740
-22,500
-7% -$1.47M 0.04% 391
2019
Q4
$22.2M Buy
332,240
+23,584
+8% +$1.55M 0.05% 363
2019
Q3
$20.7M Buy
308,656
+6,444
+2% +$413K 0.05% 373
2019
Q2
$17.9M Sell
302,212
-13,576
-4% -$751K 0.04% 405
2019
Q1
$15.9M Buy
315,788
+93,664
+42% +$4.53M 0.04% 369
2018
Q4
$8.88M Sell
222,124
-12,236
-5% -$547K 0.03% 496
2018
Q3
$11.6M Sell
234,360
-32,384
-12% -$1.67M 0.03% 480
2018
Q2
$12.3M Sell
266,744
-13,108
-5% -$590K 0.03% 468
2018
Q1
$11.9M Sell
279,852
-6,632
-2% -$275K 0.03% 471
2017
Q4
$11.1M Sell
286,484
-45,036
-14% -$1.71M 0.03% 498
2017
Q3
$11.8M Sell
331,520
-1,768
-0.5% -$58.9K 0.03% 474
2017
Q2
$10.5M Sell
333,288
-1,000
-0.3% -$31.1K 0.03% 499
2017
Q1
$10.6M Sell
334,288
-114,156
-25% -$3.38M 0.03% 482
2016
Q4
$13M Buy
448,444
+108,200
+32% +$3.04M 0.04% 418
2016
Q3
$9.57M Buy
340,244
+2,056
+0.6% +$56.3K 0.03% 496
2016
Q2
$8.28M Buy
338,188
+138,740
+70% +$3.2M 0.02% 527
2016
Q1
$4.47M Sell
199,448
-75,944
-28% -$1.63M 0.02% 620
2015
Q4
$6.27M Buy
275,392
+57,188
+26% +$1.3M 0.02% 518
2015
Q3
$4.69M Sell
218,204
-73,328
-25% -$1.57M 0.02% 586
2015
Q2
$6.16M Sell
291,532
-126,972
-30% -$2.67M 0.02% 551
2015
Q1
$8.52M Buy
418,504
+196,208
+88% +$3.98M 0.03% 460
2014
Q4
$4.35M Sell
222,296
-568
-0.3% -$10.3K 0.01% 643
2014
Q3
$3.94M Buy
222,864
+5,792
+3% +$94.3K 0.01% 659
2014
Q2
$3.44M Sell
217,072
-16,940
-7% -$256K 0.01% 691
2014
Q1
$3.47M Sell
234,012
-380
-0.2% -$5.61K 0.01% 690
2013
Q4
$3.51M Buy
234,392
+22,380
+11% +$304K 0.01% 675
2013
Q3
$2.71M Buy
212,012
+210,320
+12,430% +$2.55M 0.01% 684
2013
Q2
$19K Buy
+1,692
New +$19.1K ﹤0.01% 793

Other funds holding CTAS

Canada Life's CTAS Position: Q1 2026 in Review

Canada Life increased its Cintas (CTAS) stake by 2.5% in Q1 2026, buying an estimated $1.34M and bringing the position to 287,149 shares worth $48.7M. The position accounts for 0.09% of the portfolio, ranked #206.

Canada Life first reported a position in CTAS in Q2 2013 and has held it in 52 quarters since. The position peaked at $112M in Q3 2024. 1,431 funds tracked by Wall St. Rank hold CTAS as of Q1 2026.

  • Canada Life held 287,149 shares of Cintas worth $48.7M as of Q1 2026.
  • Canada Life bought 7,015 Cintas shares in Q1 2026, an estimated $1.34M.
  • Cintas made up 0.09% of Canada Life's portfolio in Q1 2026, its #206 holding.
  • Canada Life first reported a position in Cintas in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Cintas position peaked at $112M in Q3 2024.
  • 1,431 funds tracked by Wall St. Rank held Cintas as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.